GTHR Projected Dividend Yield
GeneThera, Inc. ( OTCBB : GTHR )GeneThera is a biotechnology company focused on zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. Co. focuses on developing molecular diagnostic tests, therapeutics, and vaccines through its proprietary robotic technologies. Co.'s proprietary Molecular Robotic/AI Platform and Therapeutic strategy is design to prevent the spread of disease from animals and at the same time, allow to better control of zoonotic infectious agents. Co. is evaluating several robotic systems for nucleic acid extraction, and is developing a vaccine for Mycobacterium Avium Sub Paratuberculosis infection. 21 YEAR PERFORMANCE RESULTS |
GTHR Dividend History Detail GTHR Dividend News GTHR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |